Does ALOGLIPTIN Cause Neoplasm malignant? 7 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Neoplasm malignant have been filed in association with ALOGLIPTIN (Alogliptin and Pioglitazone). This represents 0.5% of all adverse event reports for ALOGLIPTIN.
7
Reports of Neoplasm malignant with ALOGLIPTIN
0.5%
of all ALOGLIPTIN reports
3
Deaths
0
Hospitalizations
How Dangerous Is Neoplasm malignant From ALOGLIPTIN?
Of the 7 reports, 3 (42.9%) resulted in death, and 1 (14.3%) were considered life-threatening.
Is Neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ALOGLIPTIN. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does ALOGLIPTIN Cause?
Pemphigoid (98)
Pancreatitis (66)
Diarrhoea (60)
Nausea (60)
Rash (55)
Hypoglycaemia (46)
Vomiting (44)
Pancreatitis acute (43)
Drug ineffective (42)
Pruritus (42)
What Other Drugs Cause Neoplasm malignant?
RANITIDINE (10,648)
ADALIMUMAB (2,028)
APIXABAN (1,772)
ETANERCEPT (1,616)
METHOTREXATE (1,041)
TOFACITINIB (1,020)
RITUXIMAB (929)
INFLIXIMAB (892)
ABATACEPT (727)
RISANKIZUMAB-RZAA (715)
Which ALOGLIPTIN Alternatives Have Lower Neoplasm malignant Risk?
ALOGLIPTIN vs ALOGLIPTIN\METFORMIN
ALOGLIPTIN vs ALOGLIPTIN\PIOGLITAZONE
ALOGLIPTIN vs ALOSETRON
ALOGLIPTIN vs ALPELISIB
ALOGLIPTIN vs ALPHA.-LIPOIC ACID